AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-38323992_ITM" title="Facts and information about Committee for Advanced Therapies (CAT) Jun 2009 meeting, monthly report: Initial applications for marketing authorisation.">Committee for Advanced Therapies (CAT) Jun 2009 meeting, monthly report: Initial applications for marketing authorisation.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Committee for Advanced Therapies (CAT) Jun 2009 meeting, monthly report: Initial applications for marketing authorisation.
At its meeting of 18 to 19 Jun 2009, the European Medicines Agency's (EMEA) Committee for Advanced Therapies (CAT) adopted one draft positive opinion by majority on an initial marketing authorisation application (in accordance with Regulation (EC) No. 1394/2007). The draft opinion was transmitted to CHMP for adoption. New …
Related articles from newspapers, magazines, journals, and more
-
- Committee for Advanced Therapies (CAT) Dec 2009 meeting monthly report:...
-
News wire article from: Chemical Business Newsbase
December 18, 2009
700+ words
-
- European Medicines Agency recommends first marketing authorisation for an...
-
News wire article from: Chemical Business Newsbase
June 26, 2009
700+ words
-
- Amsterdam Molecular Therapeutics''Marketing Authorisation for Glybera delayed...
-
News wire article from: Europe Intelligence Wire
January 30, 2012
700+ words
-
- Committee for Medicinal Products for Human Use (CHMP) monthly report (14 to...
-
News wire article from: Chemical Business Newsbase
January 7, 2010
700+ words
-
- Ark Therapeutics files Cerepro application for marketing authorisation with...
-
News wire article from: Chemical Business Newsbase
December 1, 2008
700+ words
